A complete manufacturing and material records review for the component has been performed.The results confirmed that the component satisfied all material, visual and performance standards required at the time of manufacture and release.Based on the information received, the cause of the reported event was attributed to the mis-sizing (reportedly, the valve was too small).No device malfunction or adverse event on the patient has been reported and patient had a good outcome.Furthermore, from the document review performed, no manufacturing deficiencies were identified.As such, no further investigation is warranted.Should further information be received in the future, the manufacturer will provide a follow up report.
|
The manufacturer was informed of this event through patient tracking database.Based on the information on the patient's implant from, pvf-xl which was implanted on (b)(6) 2021 was explanted on (b)(6) 2022, and cna27 was implanted in the patient as a replacement.Based on the information received, the valve was explanted due to the perivalvular leak and it was determined to be too small.As reported, during the initial implant it was thought that xl could be used although it was on the upper end of the valve¿s acceptable range.The patient wasn¿t doing well upon follow up and a leak was found around the valve.Thus, the valve was explanted.The perceval plus valve was removed and a crown valve was implanted without any incident.Patient¿s recovery went well.The manufacturer was informed that no further information will be received regarding this event at this time.
|